Skip to main content
Clinical Trials/ACTRN12618000915257
ACTRN12618000915257
Recruiting
Phase 3

A Prospective Study Aimed at Preventing Osteoporosis in Patients Following an Acute Traumatic Spinal Cord Injury (ASCI) Using Early Intervention with a Potent Anti-Resorptive Therapy, Zoledronic Acid.

orthern Sydney Local Health District - Royal North Shore Hospital0 sites100 target enrollmentMay 30, 2018

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
orthern Sydney Local Health District - Royal North Shore Hospital
Enrollment
100
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 30, 2018
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
orthern Sydney Local Health District - Royal North Shore Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Adults aged 18 years and older who have sustained an acute traumatic spinal cord injury.
  • 2\. Subject has provided an informed consent.

Exclusion Criteria

  • 1\. Subjects with a non\-traumatic spinal cord injury (eg tumours, degenerative diseases of the spinal column, vascular and autoimmune disorders)
  • 2\. Subject is currently involved in another investigational device or drug study, or \<30 days since ending another investigational device of drug study or receiving an investigational agent.
  • 3\. Malignancy within the past 5 years, except for non\-melanoma skin cancers, cervical or breast ductal carcinoma in situ.
  • 4\. Subjects with a known sensitivity to any of the drugs to be administered (zoledronic acid, vitamin D if required).
  • 5\. Subject is known to have any condition or illness (acute, chronic or history) which, in the opinion of the investigator, might interfere with the evaluation of the study treatment or may otherwise compromise the safety of the patient
  • 6\. Subject has any kind of disorder that, in the opinion of the investigator, may compromise the ability of the subject to give informed consent and/or to comply with all the required study procedures
  • 7\. Female subjects who, at the time of injury, are pregnant.

Outcomes

Primary Outcomes

Not specified

Similar Trials